The weekly litigation news digest is live. Subscribe now

IP Verse

Adare I competitive analysis

Loading summary...

Latest patents of Adare I opposed by its competitors

Explore Adare I's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3041476
Jan 25, 2023Corticosteroid Containing Orally Disintegrating Tablet Compositions For Eosinophilic Esophagitis1
EP3403654
Jul 31, 2019Orally Administered Corticosteroid Compositions1
EP2482822
Aug 1, 2018Orally Administered Corticosteroid Compositions1

Latest PTAB cases involving Adare I

Discover the latest PTAB cases involving Adare I, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Adare I with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 20, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ADARE I - 3 - -
DR FALK PHARMA1026 -